What You Should Know:
- DiagnaMed Holdings Corp., a digital health artificial intelligence company focused on brain health, today announced the pilot launch of CERVAI™ a world-first consumer brain health and wellness AI solution that aims to ‘raise a red flag’ for potential brain health issues by estimating brain age and providing a brain health score.
- Based on research and development at Drexel University and the University of Miami, CERVAI™ combines a Brain Age™Estimation and Brain Health Assessment tool.
Revolutionizing Brain Health: CERVAI™ – Precision Assessments and Personalized Interventions
CERVAI™ gauges the rate of brain aging by analyzing neural activity data through an affordable EEG headset and a proprietary machine-learning model. It also evaluates overall brain health using a validated assessment, determining resilience, vulnerability, and performance. This information can guide personalized interventions, including medications or lifestyle adjustments, to potentially slow cognitive decline.
Fabio Chianelli, Chairman and CEO of DiagnaMed, commented: “After over two years in development, CERVAI™, a world-first consumer brain health and wellness solution that estimates brain age and provides a brain health score, is available to clinics seeking to provide a unique service that helps bridge the gaps in physical and cognitive health while enhancing client engagement and design personalized interventions in improving overall brain health.”
The CERVAI™ Brain Health pilot program is open to a select 25 consumer wellness clinics in the U.S. and Canada over the next three months. Ideal clinics for the pilot program must focus on health and wellness, sports and physical therapy, mental health, chiropractic care, or clinical research for neurological and cognitive disorders.
